Butalbital/Acetaminophen/Caffeine — $0 with Membership
Butalbital/Acetaminophen/Caffeine has an active canonical formulary match. No-additional-cost pricing is subject to its listed supply, quantity, fill, and fulfillment limits.
Butalbital/Acetaminophen/Caffeine Pricing
| Pricing type | Price |
|---|---|
| TheDrugClub | $0 with membership |
| Typical Retail | $117.00 |
Free with membership subject to the listed formulary limits.
About Butalbital/Acetaminophen/Caffeine
Butalbital/Acetaminophen/Caffeine is a prescription medication. Ask your doctor if Butalbital/Acetaminophen/Caffeine is right for you.
Conditions Treated with Butalbital/Acetaminophen/Caffeine
- Cluster Headache
- Cluster headache (sumatriptan)
- Menstrual migraine
- Migraine (acute)
- Status migrainosus (clinic)
- Vestibular Migraine
- Vestibular migraine (acute)
How to Check Butalbital/Acetaminophen/Caffeine Pricing
- Join TheDrugClub for $19.95/month
- Receive your member card by email
- Present your card at a participating pharmacy
- Check active-formulary eligibility or available membership pricing
Butalbital/Acetaminophen/Caffeine at Participating Pharmacies
- CVS Pharmacy
- Walgreens
- Walmart Pharmacy
- Rite Aid
- Kroger Pharmacy
- Costco Pharmacy
- Albertsons
- Safeway
- Publix Pharmacy
- H-E-B Pharmacy
Pharmacy participation and fulfillment options vary. Present your membership card and confirm current pricing before filling.
What Butalbital/Acetaminophen/Caffeine is approved for (FDA label)
Butalbital, Acetaminophen and Caffeine capsules are indicated for the relief of the symptom complex of tension (or muscle contraction) headache. Evidence supporting the efficacy and safety of this combination product in the treatment of multiple recurrent headaches is unavailable. Caution in this regard is required because butalbital is habit-forming and potentially abusable.
Source: Read the full FDA label on DailyMed. Label effective date: December 31, 2024.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.
Adverse reactions for Butalbital/Acetaminophen/Caffeine (FDA label)
Adverse Reactions Frequently Observed The most frequently reported adverse reactions are drowsiness, lightheadedness, dizziness, sedation, shortness of breath, nausea, vomiting, abdominal pain, and intoxicated feeling. Infrequently Observed All adverse events tabulated below are classified as infrequent. Central Nervous System: headache, shaky feeling, tingling, agitation, fainting, fatigue, heavy eyelids, high energy, hot spells, numbness, sluggishness, seizure. Mental confusion, excitement, or depression can also occur due to intolerance, particularly in elderly or debilitated patients, or due to overdosage of butalbital. Autonomic Nervous System: dry mouth, hyperhidrosis. Gastrointestinal: difficulty swallowing, heartburn, flatulence, constipation. Cardiovascular: tachycardia. Musculoskeletal: leg pain, muscle fatigue. Genitourinary: diuresis. Miscellaneous: pruritus, fever, earache, nasal congestion, tinnitus, euphoria, allergic reactions.
Source: FDA prescribing information (DailyMed). Set ID: f16429e2-4944-5bbc-e053-2a95a90ab528. SPL document ID: 2a9aa22e-db3d-217b-e063-6294a90a4c41. Label effective date: December 31, 2024. Read the full label.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.
Contraindications for Butalbital/Acetaminophen/Caffeine (FDA label)
Contraindications This product is contraindicated under the following conditions: -Hypersensitivity or intolerance to any component of this product -Patients with porphyria.
Source: FDA prescribing information (DailyMed). Set ID: f16429e2-4944-5bbc-e053-2a95a90ab528. SPL document ID: 2a9aa22e-db3d-217b-e063-6294a90a4c41. Label effective date: December 31, 2024. Read the full label.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.
Warnings and precautions for Butalbital/Acetaminophen/Caffeine (FDA label)
Warnings and Precautions Butalbital is habit-forming and potentially abusable. Consequently, the extended use of this product is not recommended. Hepatotoxicity Acetaminophen has been associated with cases of acute liver failure, at times resulting in liver transplant and death. Most of the cases of liver injury are associated with the use of acetaminophen at doses that exceed 4000 milligrams per day, and often involve more than one acetaminophen containing product. The excessive intake of acetaminophen may be intentional to cause self-harm or unintentional as patients attempt to obtain more pain relief or unknowingly take other acetaminophen-containing products. The risk of acute liver failure is higher in individuals with underlying liver disease and in individuals who ingest alcohol while taking acetaminophen. Instruct patients to look for acetaminophen or APAP on package labels and not to use more than one product that contains acetaminophen.
Source: FDA prescribing information (DailyMed). Set ID: f16429e2-4944-5bbc-e053-2a95a90ab528. SPL document ID: 2a9aa22e-db3d-217b-e063-6294a90a4c41. Label effective date: December 31, 2024. Read the full label.
Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.